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Mexico, 5 Pontificia Universidad Católica del Perú, Lima, Peru, 6 Maestrı́a en Sistemas de Salud y
Seguridad Social, Universidad ISALUD, Buenos Aires, Argentina, 7 Escuela de Salud Pública de Chile,
Santiago, Chile, 8 Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil, 9 Facultad de Ciencias





Influenza morbidity and mortality are significant in the countries of South America, yet influ-
enza vaccination is as low as 56.7% among pregnant women, reaching 76.7% of adults with
chronic diseases. This article measures the relative values for the vaccination hesitancy
indicators of confidence, complacency and convenience by risk-groups in urban areas of
five countries of South America with contrasting vaccination rates, analyzing their associa-
tion with sociodemographic variables and self-reported immunization status.
Methods
An exit survey was applied to 640 individuals per country in Brazil, Chile, Paraguay, Peru
and Uruguay, distributed equally across risk groups of older adults, adults with risk factors,
children�6 and pregnant women. Indicators were constructed for vaccine confidence, com-
placency and convenience. Analysis of variance and multiple logistic analysis was
undertaken.
Results
Adults with risk factors are somewhat more confident of the influenza vaccine yet also more
complacent. Convenience is higher for mothers of minors. Children and older adults report
higher levels of vaccination. The 3Cs are more different across countries than across risk
groups, with values for Chile higher for confidence and those for Uruguay the lowest.
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Complacency is lower in Brazil and higher in Uruguay. Results suggest that confidence and
complacency affect vaccination rates across risk groups and countries.
Conclusions
Influenza vaccine confidence, complacency and convenience have to be bolstered to
improve effective coverage across all risk groups in the urban areas of the countries studied.
The role played by country contextual and national vaccination programs has to be further
researched in relation to effective coverage of influenza vaccine.
Introduction
Influenza is a respiratory viral disease that is responsible for high mortality and morbidity
rates worldwide [1, 2]. The disease can be particularly severe in children younger than 6 years,
pregnant women, older adults, and adults with risk factors [3]. Influenza cases are estimated at
1 billion per year worldwide, of which 3 to 5 million are severe and lead to 290,000–650,000
deaths [1]. Vaccination is one of the most important measures to prevent influenza infection.
Influenza vaccine has been reported with up to 90% of effectiveness in the case of healthy
adults, while in older adults, effectiveness can be of 60% while reducing mortality by up to by
80% [4]. Some years, nevertheless, influenza vaccine can have a low performance due to a mis-
match with circulating strains [5].
Most Latin American countries have a seasonal influenza vaccination policy in place and
the vaccine is recommended and publicly financed for children aged under 6 years, people
with chronic comorbidity, adults aged over 60 years, pregnant women within 20 weeks of ges-
tation, or women in the postpartum period [6]. WHO recommends the attainment of 90%
coverage for all universal vaccinations for 2020 [7]. Yet among 10 countries of South America
including Brazil and those in the Andean Region and the South Cone, reported coverage for
influenza vaccination in 2018 (or the most recent year) was 61.6% of adults 60 years and older,
58.4% of children under six years of age, 56.7% of pregnant women and 76.7% of adults with
chronic conditions [8]. Vaccination coverage across all risk groups in Argentina, Bolivia, Bra-
zil, Chile, Colombia and Ecuador perform above the regional average, with Paraguay, Peru,
Uruguay and Venezuela performing below average.
The decision-making process followed by the population to get vaccinated is immersed in a
specific social context of beliefs and perceptions as well as considerations of the availability of
the vaccine and its costs [9]. The World Health Organization’s Strategic Advisory Group of
Experts proposed the concept of vaccine hesitancy defined as the delay in the acceptance or to
the rejection of vaccines despite their availability within vaccination services [10]. Vaccine hes-
itancy is the result of a complex interrelation of behavioral and societal factors whose interven-
tion requires an integral approach. Different conceptual models have been proposed to
address the complexity, applicability, and potential usefulness of vaccine hesitancy indicators,
as well as for the design of surveys and interventions that can be applied locally and globally.
The “Three Cs” model of vaccine confidence, complacency, and convenience is considered as
one of the most useful given that it is intuitive and easy to understand and apply [11]. Confi-
dence is the degree of trust in the effectiveness and safety of the vaccine, in the system that
delivers the vaccines, and in the motivations of those who make the decisions to achieve effec-
tive access to the vaccines. Lack of confidence is caused by strong negative attitudes towards
vaccination, which can be influenced by misinformation about vaccination risks, by affiliation
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to anti-vaccine groups or through legitimate concerns regarding vaccine safety and efficacy.
Complacency occurs when the risk of diseases preventable by vaccination is perceived as low,
and vaccination is not considered a necessary or the chief preventive measure. Complacency is
influenced by the relative priorities assigned to health as against other life responsibilities,
including the success of immunization programs and their impact in lowering disease preva-
lence and mortality and self-efficacy–the self-perceived or real ability of an individual to take
action to vaccinate. Convenience refers to the influence on the decision to get vaccinated of
vaccine availability, affordability, willingness to pay, ability to understand and accept vaccine-
related information (language, culture and health literacy), health service quality (real or per-
ceived) and the degree to which vaccination services are delivered at a time and place and in a
cultural context that is convenient and comfortable [12].
Influenza vaccine hesitancy can be of greater significance for coverage in comparison to
other vaccines given its seasonal character, annual variability in effectiveness and often low
perceived levels of protection, abundance of influenza-specific myths, and its recommendation
for specific risk-groups [13]. The 3C model of vaccine hesitancy has been applied to compare
across influenza and other vaccines as well as to explore and compare the role its components
play for influenza vaccine uptake. A world-wide systematic review of influenza vaccination
intention and behavior studies between 2005 and 2016 identified important barriers to vacci-
nation against influenza in all risk groups. The most frequent reasons for hesitancy were due
to low perceived risk of the disease, lack of trust in the authorities, and low perceived safety of
the vaccine [14]. Crouse Quinn and colleagues developed quantitative indicators for each of
the 3C components and found significant effects with influenza vaccine hesitancy in represen-
tative samples of African American and native white populations in the United States, as well
as different measures of hesitancy across vaccines for different diseases [15].
The role of confidence, complacency and convenience for increasing influenza vaccination
coverage needs to be further researched in specific national and local contexts and across risk
groups to identify the specific factors that can modified to reduce vaccine hesitancy and to
increase coverage. Quantitative measurement of each of the 3C vaccine hesitancy components
can facilitate the identification of context-sensitive factors associated to vaccination uptake. In
this article we explore three research questions: how different are confidence, complacency
and convenience across risk groups and countries? How are the sociodemographic characteris-
tics of risk-group members related to each of the three components of hesitancy? ¿How sensi-
tive are each of the components to self-reported vaccination uptake? To pursue these research
questions, this paper proposed indicators for confidence, complacency and convenience and
analyzes their association across risk groups and across selected countries of South America
and in relation to socioeconomic characteristics and self-reported vaccination status.
Methods
A cross-sectional quantitative study was designed to identify confidence, complacency and
convenience as determinants of influenza vaccination hesitancy and their association to vacci-
nation rates among low and middle-class residents of large cities in a sample of countries of
South America. Five countries were selected based on judgement of their vaccination rates and
aiming to include countries along the vaccination coverage continuum and to include coun-
tries in Brazil, the Andean Region and the South Cone. Brazil and Chile were selected as high
performers and Paraguay, Peru and Uruguay as low performers.
The “Three Cs” model was operationalized following Wheelock and collaborators protocol
for integrating self-reported knowledge, attitudes and practices into vaccine confidence, com-
placency and convenience indicators [10]. Pertinent and reliable vaccine hesitancy questions
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were adapted for each of the 3C components from Larson et al, who developed a set of model
survey vaccine hesitancy questions supported on a matrix of hesitancy determinants selected
through a systematic review of peer-reviewed literature and on the expertise of the SAGE
Working Group on Vaccine Hesitancy [10]. Some of these survey questions had been pilot-
tested in various world regions including the Americas through a questionnaire in Spanish.
A questionnaire was designed for each risk group structured in 41 Core Closed and Likert
Scale questions (available as S1 Questionnaire and S1 File). Most questions were the same
across risk groups, except on the specifics of pregnancy and chronic disease self-report and the
specifics of influenza and influenza vaccine risks for babies, for children, for older adults and
for adults with risk factors. Questionnaires were adapted to each country’s health care systems
to ask about health insurance coverage.
Questionnaires were developed in Spanish and pilot tested in Peru. Questionnaires were
then translated to Portuguese for application in Brazil and further pilot tested in each country
to ensure they were properly understood in the urban settings where they were going to be
applied. The questionnaire was applied to each risk group through opportunistic sampling in
two public and two private ambulatory healthcare units for a total of eight units. The health
centers were located in the following cities. In Brazil: Porto Alegre and Sao Paulo; in Chile:
Santiago and Valparaiso; in Peru: Arequipa and Lima; in Paraguay: Asunción and Ciudad del
Este, and in Uruguay: Montevideo and Salto. Primary care exit surveys were carried out in a
sample of public and private health centers with a sample of adults aged 65 years and over,
adults with risk factors, pregnant women, mothers of children aged<6 years. Exclusion crite-
ria included major impairment due to illness. Adults with risk factors included participants 18
years and older who reported at least one underlying health condition, and which included at
least one of the following: hypertension, gastritis, diabetes, cancer, chronic pulmonary diseases
or depression. Research was undertaken from October 2018 to December 2019. The protocol
was approved by research ethics committees in each of the countries studied (see detailed eth-
ics committee information in Ethics Approval below).
The sample size was not calculated based on statistical error and confidence criteria because
the selection process was not probabilistic and, therefore, was not intended to obtain estimates
with associated levels of precision (error and confidence). The number of interviews was estab-
lished based on optimization criteria seeking an adequate balance between the availability of
resources and the robustness of the results. A minimum of 640 participants were surveyed in
each country, 160 individuals for each risk group for a minimum grand total of 3,200
individuals.
Aggregated indicators for each of the 3C components were constructed through coding
questions to each of the 3C indicators and averaging their component variables. Indicators for
complacency subcomponents of prejudices, knowledge and risk perception were also con-
structed. Table 1 details the construction of each component and subcomponent. The vaccine
confidence indicator was constructed based on three questions on vaccine safety and effective-
ness, each based on a five-point Likert scale for up to 12 points. The vaccine complacency com-
ponent and subcomponents were constructed based on nine questions for a total of up to 41
points among dichotomous and Likert scale responses as well as a list of up to fifteen influenza
symptoms. One point was considered for each correct symptom mentioned. The vaccine con-
venience indicator was constructed adding values for five dichotomous responses related to
vaccine recommendation and access with up to five points each, for a total of 5 points. Values
within each of the 3Cs and in the case of Complacency within each sub-indicator were stan-
dardized in a scale of 0 to 10, with greater value for more confidence and convenience and less
complacency. Within the complacency subcomponents, a greater value is allocated to less prej-
udice, more knowledge and more risk perception of influenza risks.
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One-way ANOVA pairwise multiple comparison tests were applied to analyze the signifi-
cance of differences in means across risk groups and countries for the aggregate 3C indicator,
the separate 3C components and subcomponents of complacency as well as of vaccination sta-
tus (at least once in the life-course and in the last year). Analysis of variance was applied to
assess the significance of the association between the 3C components and sociodemographic
variables, risk groups and countries. Binary logistic multivariate regression analysis was
applied to assess the association within each risk group between vaccine confidence, conve-
nience and complacency and vaccination status. The processing and analysis of the informa-
tion was carried out using the IBM-SPSS V.24 package.
Ethics approvals
The following ethics committee reviewed the protocol within each of the study countries:
Brazil, Comissao Nacional de Ética em Pesquisa, 05215918.6.0000.5347.
Table 1. Construction of confidence, complacency and convenience indicators.
Indicator Description Questionnaire items� Construction Measurement scale (and points)
Confidence in the
vaccine
Level of perception of
the efficacy and safety
of the vaccine
24.1: "Vaccine efficacy level". The scale was additive according to
ordinal answers obtained in questions.
Resulting sum is rescaled to the interval
(0, 10).
From low confidence (0 Pnts.) to
high confidence (12 Pnts.) The
more confidence, the less
hesitation to vaccinate
24.2: "Vaccine safety level".
25.1: "The vaccine is very effective"
Complacency A.
Influenza risk
Level of perception of
the risk of contracting
influenza and its
severity
24.3: "Level of risk of contracting
influenza.�
Idem. From low risk (0 Pnts.) to high
risk (8 Pnts.) The greater the risk,
the less hesitation to be
vaccinated





Level of knowledge of
influenza and its
vaccine
11: "You know what influenza is.� The scale was additive for positive
answers in each of the questions.
Resulting sum is rescaled to the interval
(0, 10).
From low knowledge (0 Pnts.) to
high knowledge (25 Pnts.) The
more knowledge, the less
hesitation to vaccinate
12: "Main symptoms of influenza.�
13: "You know the vaccine exists"
25.5: "It is advisable to vaccinate
against influenza every year."
25.6: "Only minors and the elderly
should be vaccinated." (Calculated in
an inverted sense to be consistent with






25.2: "The vaccine has side effects." The scale was additive according to
ordinal answers obtained in questions.
Resulting sum is rescaled to the interval
(0, 10). (The score complement is used
to be consistent with the direction of the
indicator)
From low prejudice (0 Pnts.) to
high prejudice (8 Pnts.) A lower
value, less prejudice and less
hesitation to get vaccinated
25.4: "The vaccine causes reactions."
Convenience Level of convenience
perceived in accessing
the vaccine
19. Who recommended you get
vaccinated?
The scale was additive. Resulting sum is
rescaled to the interval (0, 10).
From low convenience (0 Pnts.)
to high convenience (5 Pnts.) The
more convenience, the less
hesitation to vaccinate
20. Do you know where to go to get a
flu shot?
22. Is the vaccine available at the
health facility where you go regularly?
23. How long does it take to get from
your home to the health facility you
go to regularly?
25.3 Is the flu vaccine difficult to
obtain?
� Reference is made to the questionnaire for Adults with Risk factors. Questionnaires for other risk groups specified question 25.6. Questionnaire is available as S1
Questionnaire.
https://doi.org/10.1371/journal.pone.0243833.t001
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Chile: Comité de Ética de Investigación en Seres, Universidad de Chile, Facultad de Medi-
cina, 191–2018.
Paraguay: Comité de ética en Investigación, Laboratorio Central de Salud Pública, 106/
2019.
Peru: Comité de Ética de Investigación Prisma, CE1651.18.
Uruguay: Comité de Ética en Investigación, Instituto Nacional de Salud Pública, 1580.
Mexico: Comité de Ética en Investigación, Instituto Nacional de Salud Pública, Proyecto
CI: 1580.
Results
Women constituted between 67.7 and 69.4% of respondents in the groups of older adults and
adults with risk factors (Table 2). Mean age was 71.8 for older adults, 51 years for adults with
risk factors, 27.8 for pregnant women and 30.5 for mothers of minor children. Education levels
were higher among pregnant women and mothers of minor children than for adults with risk
factors and older adults, with 8.1 and 9.3% of the former having up to primary education, as
against 26.9 and 38.8% of the latter, respectively. Adults with risk factors reported as the most
prevalent diseases hypertension (43%), diabetes (22%) and gastritis or gastric ulcer (14%).
Across countries, average age was similar while Paraguay and Uruguay registered the largest
percentages of respondents with up to primary education, while Uruguay had to second lowest
level of respondents with higher education.
Table 2. Sociodemographic characteristics of survey participants by country and risk group.
Sex (%) Age (years) Education level (%)
Male Female Minimum Maximum Average Up to primary Secondary Technical Higher education
Elderly adults (n = 802) Brazil 28.8 71.3 62 92 71.3 31.3 12.5 28.1 28.1
Chile 21.6 78.4 65 89 71.6 27.8 45.7 8.6 17.9
Paraguay 35.6 64.4 65 91 69.8 48.1 14.4 16.9 20.6
Peru 38.8 61.3 65 95 73.3 39.4 39.4 10.0 11.3
Uruguay 36.9 63.1 65 92 73.1 47.5 20.6 11.9 20.0
All 32.3 67.7 62 95 71.8 38.8 26.6 15.1 19.6
Adults with risk factors (n = 808) Brazil 38.1 61.9 18 79 49.2 22.0 14.9 35.7 27.4
Chile 16.3 83.8 21 73 45.0 19.4 33.1 13.1 34.4
Paraguay 25 75 29 80 53.3 38.8 19.4 16.9 25.0
Peru 39.4 60.6 23 96 58.0 23.1 38.1 21.3 17.5
Uruguay 33.8 66.3 21 64 49.8 31.3 24.4 23.1 21.3
All 30.6 69.4 18 96 51.0 26.9 25.9 22.2 25.1
Pregnant women (n = 801) Brazil - 100 18 42 28.2 5.6 14.4 48.8 31.3
Chile - 100 18 41 27.8 3.8 39.4 17.5 39.4
Paraguay - 100 14 42 27.5 8.1 25.6 18.8 47.5
Peru - 100 15 41 27.0 3.8 46.3 27.5 22.5
Uruguay - 100 16 48 28.2 19.4 28.8 27.5 24.4
All - 100 14 48 27.8 8.1 30.9 28.0 33.0
Mothers of children <6 (n = 800) Brazil - 100 18 50 31.0 4.4 8.2 47.2 40.3
Chile - 100 18 48 30.3 4.4 38.8 22.5 34.4
Paraguay - 100 16 47 29.9 15.6 19.4 29.4 35.6
Peru - 100 16 50 31.9 6.9 36.3 38.8 18.1
Uruguay - 100 16 49 29.3 15.0 36.3 21.3 27.5
All - 100 16 50 30.5 9.3 27.8 31.8 31.2
https://doi.org/10.1371/journal.pone.0243833.t002
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Table 3 presents the score values for the 3C components together with the statistical results
of comparisons across risk groups and countries. All differences are at p < .001 unless other-
wise noted. The confidence indicator for adults with risk factors (6.51) is slightly higher than
for the rest of the risk groups (6.27 to 6.37). Adults with risk factors and mothers have signifi-
cantly lower scores for complacency (4.86 and 4.78), meaning they are more complacent–than
scores for pregnant women and older adults (4.72 and 4.78). Scores for knowledge of the vac-
cine are lower for older adults (3.53) followed by adults with risk factors (3.93), with higher
and similar scores for the other two groups. Scores for the perception of influenza risks are not
significantly different across groups. The convenience score shows minor but significant dif-
ferences between mothers with a higher score (7.67) in comparison to the other risk groups
(7.36 to 7.46).
Self-reported vaccination rates across risk groups were significantly different only for vacci-
nation in the last year. Children and older adults report significantly higher levels of vaccina-
tion (56.4 and 51.6%, respectively) than the older adults (45.7%) and pregnant women
(48.9%). Vaccination at least once in the lifetime ranged from 60.3 to 64.1% across risk groups.
The analysis of the 3C scores by country shows greater differences than those observed
across risk groups. Scores for the confidence indicator are significantly different across all
countries, with Chile (7.48) and Uruguay (5.99) at the extremes. Complacency–with less con-
trasts across countries–shows significant differences between Brazil as least complacent (4.98),
Paraguay, Peru and Chile (4.81 to 4.79) and Uruguay (4.45). However, the scores for the sub-
components of complacency show marked contrasts across countries. The prejudices subcom-
ponent score groups Paraguay and Peru with least prejudices (5.29 and 5.24), followed by
Brazil and Uruguay (4.93 and 5.16) and then by Chile (4.21). With regard to the score for vac-
cine knowledge, Brazil and Chile rank highest (4.11 and 4.02), followed by Peru, Paraguay and
Uruguay (31.4 to 3.81), in that order. The perception of influenza risk scores highest in Chile
(5.94), followed by Brazil and Paraguay and, without significant differences, by Peru and Uru-
guay (5.33 to 5.27).
Table 3. Comparison across risk groups and countries between the means of individual scores of confidence, complacency, convenience � and the percentage of vac-
cinated individuals.










Brazil Chile Paraguay Peru Uruguay (n = 3,211)
(n = 649) (n = 642) (n = 640) (n = 640) (n = 640)
Confidence 6.37 (a) 6.51 (b) 6.27 (a) 6.36 (a) 5.78 (A) 7.48 (E) 6.2 (C) 6.46 (D) 5.99 (B) 6.38
Complacency 4.72 (a) 4.86 (c) 4.65 (a) 4.78 (b) 4.98 (C) 4.72 (B) 4.81 (B) 4.79 (B) 4.45 (A) 4.75
-Less prejudiced about
the vaccine
4.98 (a) 5.08 (b) 4.82 (a) 4.98 (a) 5.16 (B) 4.21 (A) 5.29 (C) 5.24 (C) 4.93 (B) 4.97
-Knowledge of
influenza and vaccine
3.53 (a) 3.93 (c) 3.68 (b) 3.8 (b) 4.11 (D) 4.02 (D) 3.6 (B) 3.81 (C) 3.14 (A) 3.74
-Perception of risk of
influenza
5.63 (a) 5.58 (a) 5.44 (a) 5.55 (a) 5.68 (C) 5.94 (D) 5.53 (B) 5.33 (A) 5.27 (A) 5.55
Convenience 7.36 (a) 7.44 (a) 7.46 (a) 7.67 (b) 7.53 (B) 8.65 (C) 6.85 (A) 6.85 (A) 7.53 (B) 7.48
Vaccinated at least
once in life course (%)
61.7 (a) 60.3 (a) 63.2 (a) 64.1 (a) 78.6 (D) 87.9 (E) 51.4 (B) 58.4 (C) 35.0 (A) 6.23
Vaccinated in the last
year (%)
51.6 (b) 45.7 (a) 48.9 (a) 56.4 (b) 66.3 (C) 79.1 (D) 37.5 (B) 42.5 (B) 27.5 (A) 5.06
�Scale of 0 to 10 according to more confidence and convenience and less complacency (less prejudice, more knowledge and greater risk perception). In parenthesis, the
same letter is assigned to means without statistically significant difference across risk groups or countries at p < .001.
https://doi.org/10.1371/journal.pone.0243833.t003
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Vaccination status is also highly contrasting across countries, with significant differences in
the percentages of individuals vaccinated across all of them and for both status indicators,
except for vaccination in the last year which are not significantly different for Paraguay and
Peru. Chile shows the highest levels of vaccination in the life-course (87.9%) and in the last
year (79.1%), followed by Brazil also for both indicators. Uruguay has the lowest vaccination
rates, with 35.0% for vaccination in the life-course and 27.5% for vaccination in the last year.
With regard to the association between the 3C indicator scores and independent sociode-
mographic variables (Table 4), the score for confidence was significantly associated to older
age in the case of pregnant women, to more education in the case of older adults and for the
sample as a whole, and with sex only for the sample as a whole (considering only the groups of
older adults and adults with risk factors), with male respondents being more confident than
female respondents. In the case of complacency, older age was significantly associated with
pregnant women (p< .05) and to mothers and for the sample as a whole (p< .01). (Less) com-
placency was associated with more education for all risk groups (p< .01), and not at all with
sex. In the case of convenience, older age was only associated for mothers (p< .05) while more
education was associated for older adults (p< .01), adults with risk factors (p< .05) and for
the sample as a whole (p< .01). Sex was also associated in the case of convenience for adults
with risk factors and for the sample as a whole (p< .01), with females finding in general vac-
cine services more convenient.
Multivariate logistic regression analysis shows a significant and positive association
between each of the 3C indicators and vaccination status across each risk group (p< .001 for
all associations), except for the relationship between complacency and vaccination in the last
year among older adults (p< .005) and among pregnant women which is not significant
(Table 5). Across risk groups and considering both vaccination statuses, confidence has the
highest odds ratio among older adults (OR: 1.709) and pregnant women (OR: 1.562) while
complacency shows the highest odds ratios in the case of adults with risk factors (OR: 1.715)
followed by older adults (OR 1.662). Comparing odds ratio for vaccination across the 3Cs,
Table 4. Association between sociodemographic variables in relation to the 3C indices by risk group, using analy-
sis of variance models.
Confidence Complacency Convenience
A B A B A B
Age
OA NS - NS - NS -
ARF NS - NS - NS -
PW < .05 (+) < .05 (+) NS -
MCh NS - < .01 (+) < .05 (+)
Education
OA < .01 (+) < .01 (+) < .01 (+)
ARF NS - < .01 (+) < .05 (+)
PW NS - < .01 (+) NS -
MCh NS - < .01 (+) NS -
Sex
OA NS - NS - NS -
ARF NS - NS - < .01 M-F
A. Significance (p-value), NS: Not significant. B. Tendency of association: For Education and Age: (+) positive; (-)
negative. For Sex, extreme values are indicated: sex with lower value–sex with higher value. M (Male), F (Female).
OA: Older adults; ARF: Adults with risk factors; PW: pregnant women; MCh: mothers of children <6.
https://doi.org/10.1371/journal.pone.0243833.t004
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odds ratios are generally lower for convenience, although for pregnant women and mothers
these odds are somewhat higher or at the same level than for complacency (OR: 1.040 and
1.033, respectively).
Discussion
The study is the first to apply a multi-country quantitative approach to the analysis of influenza
vaccination hesitancy in South America. The study is limited to non-probabilistic samples of
large urban health service user populations and must be interpreted with caution, as health ser-
vice users may in general find services more accessible and may thus manifest less hesitancy
towards vaccines and show also higher vaccination rates than non-users. However, the age and
insurance protection in the surveyed population as well as vaccination coverage rates were
found to be close to those observed in other more representative sources of information. Most
respondents were women, not only given their role in pregnancy and as mothers, but also
being over-represented in the groups of older adults and adults with risk factors [7]. It is note-
worthy that reported vaccination rates in the last year across risk groups and countries are
somewhat lower than those officially reported, particularly for the case of adults with risk fac-
tors [8]. This could be due to differences in measurement methods. On the demand side,
reporting may be influenced by loss of memory. On the demand side, overreporting can occur
given that coverage is estimated on the number of doses applied against the number of doses
planned. Planification is particularly difficult for adults with risk factors given limited informa-
tion on chronic disease prevalence.
The analysis of the 3C indicator levels by risk groups revealed small but significant differ-
ences across risk groups, except for influenza risk perception. Adults with risk factors show in
general somewhat better indicators across the 3Cs while older adults were always placed in the
lowest scores across all indicators, while all other risk groups scored higher than them in the
knowledge sub-indicator. Differences across risk groups can support discussion of specific
strategies to bolster confidence and convenience and to reduce complacency. In contrast with
the 3C levels, we found important differences across the vaccination rates reported by risk
groups, with the lowest value for adults with risk factors and the highest for children under six
years of age.
Our study found the most significant and contrasting differences in the 3C component
indicator levels and vaccination rates across countries. Chile is associated to highest confidence
and highest vaccine and influenza knowledge as well as to the highest perception of influenza
risks, but also to the highest level of perception of prejudices to the vaccine. Importantly,
Table 5. Odds ratio of influenza vaccination (at least once in the lifetime and in last year) and vaccine confidence, complacency and convenience, by risk group. All
countries. Binary logistic multivariate regression analyses (enter method to select variables).
OR CI p-value OR CI p-value OR CI p-value
Older adults A 1.635 1.429–1.871 < .001 1.662 1.372–2.012 < .001 1.247 1.112–1.398 < .001
B 1.709 1.501–1.944 < .001 1.268 1.076–1.494 < .005 1.220 1.095–1.358 < .001
Adults with risk factors A 1.311 1.183–1.452 < .001 1.715 1.448–2.031 < .001 1.289 1.168–1.422 < .001
B 1.361 1.229–1.507 < .001 1.414 1.213–1.648 < .001 1.337 1.211–1.475 < .001
Pregnant women A 1.562 1.368–1.784 < .001 1.272 1.070–1.513 < .001 1.485 1.336–1.650 < .001
B 1.437 1.270–1.625 < .001 1.093 0.938–1.273 NS 1.400 1.267–1.546 < .001
Mothers of children A 1.299 1.150–1.467 < .001 1.382 1.168–1.636 < .001 1.381 1.239–1.541 < .001
B 1.313 1.170–1.473 < .001 1.346 1.152–1.572 < .001 1.322 1.192–1.465 < .001
OR: Odds ratio; CI: Confidence Interval (95%). A: Vaccinated at least once in the lifetime; B: Vaccinated in the last year.
https://doi.org/10.1371/journal.pone.0243833.t005
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respondents from Chile also reported the highest rates of vaccination, coincident with official
reports [8]. At the other end, respondents from Uruguay observed the lowest confidence, the
most complacency and the least knowledge, together with the lowest reported vaccination
rates, also congruent with the official reports. Brazil, Paraguay and Peru rank in the middle of
the measured 3C component indicators.
Differences across countries in the 3C component indicators and vaccination rates point to
contextual and vaccination program differences. With exceptions, we did not find associations
between age and sex with confidence or convenience. Education was associated to compla-
cency for all risk groups but only to confidence for older adults and for the sample as a whole.
Education by country in our sample is aligned to the 3C and vaccination rate findings, with
respondents in Chile reporting the lowest number with up to primary education while those
from Uruguay and Paraguay, the highest.
Our research supports previous findings attesting to the importance of confidence and
complacency in hesitancy to influenza vaccination uptake [14, 15]. Reinders and colleagues
found confidence as the most prevalent reason for not being vaccinated, specifically “being
afraid of vaccination and its effects”. They also found greater vaccination rates among persons
who most perceived the severity of influenza [16]. We found confidence to be the hesitancy
factor most associated to vaccination uptake, particularly among older adults and pregnant
women, with complacency being more important among adults with risk factors. A one-point
increase in the confidence indicator among older adults would lead to an expected increment
of 49% in the probability of being vaccinated at least once; in the case of complacency among
adults with risk factors the expected increment would be of 54% and in the case of convenience
among minors the increment would be of 32%. These values suggest the importance of
addressing influenza vaccination through specific strategies to address each of the 3C
indicators.
The COVID-19 pandemic and its devastating effects at the global level calls to prepare vac-
cination policies and strategies at global, regional and country levels [17]. Our study results
point toward valuable lessons to ensure that vaccine confidence is bolstered through effective
communication on its expected effectiveness and safety. It is likely COVID-19 has already
decreased seasonal influenza vaccine complacency; however, our results suggest that compla-
cency should not take it for granted, and that COVID-19 vaccination when available–should
address complacency as a potential barrier to effective coverage.
Conclusions and recommendations
The analyses carried out on the demand side of influenza vaccination in urban areas of South
America enabled the identification of strong benefits from increasing the three 3C compo-
nents of vaccine hesitancy, particularly confidence and complacency. The study suggests
diverse opportunities and pathways are open to strengthening the 3C components, which
show greater variation across countries than across risk groups. The higher values identified
for vaccine convenience suggest this component has been more successful in the implementa-
tion of influenza vaccination campaigns, although opportunities still exist for improvement.
Strategies to bolster confidence and to reduce complacency should be supported on the
strengths of vaccine convenience.
It is recommended to investigate the contextual and vaccination program factors that are
affecting the perception of confidence and complacency and vaccination rates across the coun-
tries studied and in relation to each of the risk groups. Information and communication cam-
paigns, normative messaging and performance incentives can be strengthened to focus on
those aspects that affect confidence and complacency. With the advent of COVID-19 lessons
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learnt with influenza vaccination can play a useful role to identify strategies to ensure confi-
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